Refractory Angina Pectoris Clinical Trial
Official title:
Randomized, Placebo Controlled, Double Blind Clinical Trial Evaluating the Treatment of Patients With Refractory Angina Pectoris With Low Intensity Extracorporeal Shockwave Therapy Device
Low intensity shockwaves have been proven in animal studies to induce local growth of new
blood vessels from existing ones.
The hypothesis of this study is that shockwave therapy could improve the symptoms of
patients with refractory angina not amenable to revascularization with angioplasty or bypass
surgery.
Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to myocardial
ischemic tissue. Shockwaves are created by a special generator and are focused using a
shockwave applicator device. The treatment is guided by standard echocardiography equipment.
The shockwaves are delivered in synchronization with Patient R-wave to avoid arrhythmias.
The treatment is painless.
At first, the patient undergoes stress- SPECT testing to identify the ischemic areas.
Following that, the same area is localized by the ultra-sound device and the shockwaves are
focused to the ischemic area. Several treatments are required for optimal results.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03438500 -
Cardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve
|
N/A | |
Recruiting |
NCT01711099 -
Efficacy of Extracorporeal Shockwave Myocardial Revascularization
|
N/A | |
Active, not recruiting |
NCT03039751 -
Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris
|
Phase 2 | |
Suspended |
NCT01567592 -
Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris
|
Phase 1 | |
Recruiting |
NCT05711849 -
Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
|
Phase 2 | |
Active, not recruiting |
NCT01241968 -
Extracorporeal Shock Wave Therapy for the Treatment of Ischemic Heart Disease
|
Phase 2 | |
Recruiting |
NCT02499250 -
Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients
|
N/A | |
Completed |
NCT01219218 -
Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris
|
Phase 1 | |
Active, not recruiting |
NCT01567644 -
Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris
|
Phase 1 | |
Completed |
NCT04121845 -
CoROnary SinuS Reducer implantatiOn for ischemiA reDuction
|
N/A | |
Active, not recruiting |
NCT05174572 -
IMR Evaluation in Patients With Coronary Sinus Reducer Implantation (INROAD Study)
|
N/A | |
Recruiting |
NCT04915157 -
Efficacy of Spinal Cord Stimulation in Patients With Refractory Angina Pectoris
|
N/A | |
Completed |
NCT01508910 -
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
|
Phase 3 |